Abnormal Liver Function Tests in Patients With COVID‐19: Relevance and Potential Pathogenesis
Anna Bertolini(University Medical Center Groningen), Giulia Peserico(Istituto Oncologico Veneto), Henkjan J. Verkade(Cystic Fibrosis Foundation), Mario Strazzabosco(Yale University), Fabio Farinati(University of Padua), Ivo P. van de Peppel(University Medical Center Groningen), Frank A.J.A. Bodewes(University Medical Center Groningen), Alberto Fantin(Istituto Oncologico Veneto), Romina Fiorotto(University of Bergamo), Han Moshage(University Medical Center Groningen), Johan W. Jonker(University Medical Center Groningen)
Cited by 302
Related Papers
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances
|Hepatology|2018|340
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma
|Journal of Hepatology|2018|187
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
|The Lancet Oncology|2023|184